Skip to main content

Table 1 Univariate analysis of the risk factors of death from cancer progression within 1 year after hepatectomy

From: Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma

  

Group ED (n = 48)

Group NED (n = 465)

p -value

Sex

Male

40

387

 
 

Female

8

78

0.9849

Age

<60

24

211

 
 

60 ≤

24

254

0.5405

HBV

+

26

195

 
 

-

22

270

0.1033

HCV

+

14

175

 
 

-

34

290

0.2469

Albumin

<4

33

214

 

(g/dl)

4 ≤

15

251

0.0027

Total bilirubin

<0.8

32

283

 

(mg/dl)

0.8 ≤

16

182

0.4314

ICGR15 (%)

<15

27

250

 
 

15 ≤

21

215

0.7421

Child-Pugh

A

42

457

 
 

B

6

8

<0.0001

AFP (ng/ml)

≤200

15

355

 
 

200<, ≤1,000

5

37

 
 

1,000<

28

73

<0.0001

AFP-L3 (%)

≤15

23

334

 
 

15% < 40<

5

49

 
 

40<

20

83

0.0002

PIVKA-II (mAU/ml)

≤100

10

258

 
 

100<, ≤1,000

8

93

 
 

1,000<

30

114

<0.0001

Liver cirrhosis

Present

17

158

 
 

Absent

31

307

0.8414

Curability

R0 R1

40

443

 
 

R2

8

22

0.0008

Anatomical resection

Yes

42

326

 
 

No

6

139

0.0108

Tumor number

1

16

321

 
 

2, 3

11

113

 
 

4 ≤

21

31

<0.0001

Tumor size

≤2 cm

4

64

 
 

2-5 cm

6

254

 
 

5 cm ≤

38

147

<0.0001

Macroscopic vascular invasion

Absent

28

440

 

(portal vein, hepatic vein)

Present

20

25

<0.0001

Differentiation

Well

0

50

 
 

Moderate

19

308

 
 

Poor

29

92

 
 

Necrosis

0

15

<0.0001

Microscopic portal vein invasion

vp0

10

369

 
 

vp1

13

60

 
 

vp2

7

15

 
 

vp3

12

15

 
 

vp4

6

6

<0.0001

Microscopic hepatic vein invasion

vv0

28

439

 
 

vv1

8

12

 
 

vv2

9

10

 
 

vv3

3

4

<0.0001

Distant metastasis

Absent

43

459

 
 

Present

5

6

<0.0001

  1. HCC: hepatocellular carcinoma.
  2. NED: alive 1 year after hepatectomy.
  3. ED: death due to HCC recurrence or progression within 1 year after hepatectomy.
  4. HBV: hepatitis B virus s antigen.
  5. HCV: anti-hepatitis C virus antibody.
  6. ICGR15: indocyanin green retention rate at 15 min.
  7. AFP: alpha-fetoprotein.
  8. AFP-L3: Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein.
  9. PIVKA-II: protein induced by vitamin K absence or antagonism factor II.
  10. vp0: no tumor thrombus in the portal vein.
  11. vp1: tumor thrombus distal to the second branches of the portal vein.
  12. vp2: tumor thrombus in the second branches of the portal vein.
  13. vp3: tumor thrombus in the first branch of the portal vein.
  14. vp4: tumor thrombus extension to the trunk or the opposite side branch of the portal vein.
  15. vv0: no tumor thrombus in the hepatic vein.
  16. vv1: tumor thrombus in a branch of the hepatic vein.
  17. vv2: tumor thrombus in the right, middle, or left hepatic vein trunk or the short hepatic vein.
  18. vv3: tumor thrombus to the inferior vena cava.